Problem of Aging Clinical Trial
Official title:
Volume Restoration of the Aging Midface With Sculptra Aesthetic
Verified date | October 2013 |
Source | Williams Center Plastic Surgery Specialists |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to examine the effect of Sculptra Aesthetic on the cosmetic
rejuvenation of the midface complex. The investigators plan to both qualitatively determine
the restoration of midface architecture as well as quantitatively document the change in
midface volume by employing three-dimensional (3D) surface imaging which critically analyzes
volumetric tissue changes. Our hypothesis is that patients who receive Sculptra Aesthetic
injections will experience significant improvement in facial midface volume restoration.
- Measure the midfacial volumetric correction from Sculptra Aesthetic treatment, using
three-dimensional digital surface imaging
- Determine the mean change from baseline in facial contour via quantitative volumetric
measurements
- Correlate volumetric correction with clinical improvement as measured by the Facial
Lipoatrophy Panel grading system
- Correlate the mean volumetric change in midfacial treatment area with the amount of
product used
- Obtain photographs pre- and post-treatment for the purpose of providing a subject visual
aid during the course of treatment
- Collect safety data
Status | Completed |
Enrollment | 15 |
Est. completion date | June 2013 |
Est. primary completion date | June 2012 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 40 Years to 60 Years |
Eligibility |
Inclusion Criteria: - Age 40-60 years old - BMI greater than 18.5 and less than 24.9 Exclusion Criteria: - Age less than 40 years or greater than 60 years - Prior surgical or non-surgical treatment to the midface within the past 2 years - Interested in seeking other treatments to the midface during the study period - Pregnant, lactating, or breast feeding - Hypersensitivity to poly-L-lactic acid, carboxymethylcellulose, or mannitol - Allergy to lidocaine or epinephrine - History of atopy, anaphylaxis, or multiple severe allergies - Current immunotherapy or history of autoimmune disease - History of or active stroke or myocardial infarction - History of or active connective tissue disease - History of or active bleeding disorders - History of or active cancer - Serious abnormalities in laboratory findings - Active hepatitis - Active infection or inflammatory process of skin - History of or risk factors for hypertrophic scarring or keloid formation |
Country | Name | City | State |
---|---|---|---|
United States | Williams Center Plastic Surgery Specialists | Latham | New York |
Lead Sponsor | Collaborator |
---|---|
Williams Center Plastic Surgery Specialists | Sanofi |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from baseline in midfacial volume from Sculptra Aesthetic treatment, using three-dimensional digital surface imaging | 6 mo, 9 mo, 12 mo, 15 mo | ||
Secondary | Correlate volumetric correction with clinical improvement as measured by the Facial Lipoatrophy Panel grading system | 12 mo | ||
Secondary | Correlate the mean volumetric change in midfacial volume with the amount of product used | 12 mo | ||
Secondary | Time course and duration of volumetric correction from Sculptra Aesthetic treatment | 6 mo | ||
Secondary | Time course and duration of volumetric correction from Sculptra Aesthetic treatment | 9 mo | ||
Secondary | Time course and duration of volumetric correction from Sculptra Aesthetic treatment | 12 mo | ||
Secondary | Time course and duration of volumetric correction from Sculptra Aesthetic treatment | 15 mo |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT02679924 -
A Slit Face Trial Using Micro-injections of Transparent Hyaluronic Acid Gel for Rejuvenation of the Cheek
|
N/A | |
Completed |
NCT02651233 -
Factors That Influence Adipose Derived Regenerative Cells' Yield and Viability
|
N/A | |
Completed |
NCT01365104 -
Modulation of Cerebral Blood Flow Using Iron Chelators
|
Phase 0 | |
Completed |
NCT01376011 -
Modulation of Cerebral Blood Flow Using Quercetin, a Nutritional Supplement
|
Phase 0 | |
Completed |
NCT02532725 -
Work-Related Effects of Heat, Activity, and Fat in Middle Aged Men
|
N/A |